Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for recurrent pterygium
IRCT201010054856N1Phase 2Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Dec 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in pterygium, sponsored by Baqiyatallah University of Medical Sciences. Started Dec 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on IRCT201010054856N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201010054856N1.